Publication | Closed Access

Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer

Primary Liver CancerHepatologyHealth SciencesTumor HeterogeneityMedicineLiver PhysiologyPharmacologyPathologyPatient-derived Organoid ModelsHepatotoxicityLiver CancerOncologyDrug-induced Liver InjuryTumor MicroenvironmentCancer ResearchDrug Resistance